Suchergebnisse
Why Huntington Ingalls (HII) is a Top Stock for the Long-Term
Here at Zacks, we offer our members many different opportunities to take full advantage of the stock market, as well as how to invest in ways that lead to long-term success.
One of our most popular
Flagstar Bank, National Association Q2 Earnings Call Highlights
Key Points
- Interested in Flagstar Bank, National Association? Here are five stocks we like better.
- Flagstar posted its third consecutive quarter of profitability, with GAAP earnings of $0.06
Otis Service Growth Builds Momentum as Equipment Demand Stays Weak
Otis Worldwide Corporation OTIS is leaning harder on its recurring Service business as New Equipment demand stays uneven. Maintenance, repair and modernization now carry more of the revenue story
FedEx Freight Targets Margin Growth as LTL Demand and Pricing Shift
FedEx Freight (FDXF) is entering public markets as a pure-play less-than-truckload carrier at a time when volume growth remains uneven. The company’s investment case now rests on whether pricing,
5 High ROE Stocks to Buy as Surging Oil Prices Rattle Investors
The broader equity markets stumbled midweek after a relatively healthy start as oil prices surged following repeated attacks by Iran and the Tehran-backed Houthi militant group and retaliation by
Is NOK Stock Worth Buying as AI Growth Offsets Telecom Challenges?
Nokia Corporation NOK offers investors a balanced investment case as growing demand for AI infrastructure helps offset continued weakness in parts of the telecom equipment market. The company is
Intel Stock Outlook as AI and Foundry Growth Reshape INTC Strategy
Intel Corporation INTC is reshaping its business around artificial intelligence, enterprise infrastructure and advanced manufacturing as it reduces its reliance on the traditional PC market. The
AngloGold Ashanti (AU) Outpaces Stock Market Gains: What You Should Know
In the latest close session, AngloGold Ashanti (AU) was up +1.59% at $79.67. The stock's change was more than the S&P 500's daily gain of 0.05%. Elsewhere, the Dow saw an upswing of 0.46%, while the
Rocket Lab- vs. AST SpaceMobile-Aktie: Auftragsbuch gegen Kriegskasse
Zwei Weltraum-Titel, ein brutaler Ausverkauf – und trotzdem völlig unterschiedliche Geschichten dahinter. Während der…
Der Beitrag Rocket Lab- vs. AST SpaceMobile-Aktie: Auftragsbuch gegen
EQS-News: Crédit Mutuel Asset Management: Fed lässt Zinsen unverändert
Bear of the Day: AngloGold Ashanti (AU)
AngloGold Ashanti (AU) is a Zacks Rank #5 (Strong Sell) that is experiencing the flip side of the gold trade. The stock rode bullion's historic run to a 52-week high of $132 earlier this year, but
Why Investors Need to Take Advantage of These 2 Retail and Wholesale Stocks Now
Wall Street watches a company's quarterly report closely to understand as much as possible about its recent performance and what to expect going forward. Of course, one figure often stands out among
How to Boost Your Portfolio with Top Business Services Stocks Set to Beat Earnings
Wall Street watches a company's quarterly report closely to understand as much as possible about its recent performance and what to expect going forward. Of course, one figure often stands out among
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Wall Street watches a company's quarterly report closely to understand as much as possible about its recent performance and what to expect going forward. Of course, one figure often stands out among
Astrazeneca (AZN) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
Astrazeneca (AZN) reported $15.38 billion in revenue for the quarter ended June 2026, representing a year-over-year increase of 6.4%. EPS of $2.63 for the same period compares to $2.18 a year ago.
Earnings Growth & Price Strength Make Prologis (PLD) a Stock to Watch
Here at Zacks, we offer our members many different opportunities to take full advantage of the stock market, as well as how to invest in ways that lead to long-term success.
The Zacks Premium
Wall Street Analysts Predict a 160.09% Upside in Ascentage Pharma Group International - Unsponsored ADR (AAPG): Here's What You Should Know
Ascentage Pharma Group International - Unsponsored ADR (AAPG) closed the last trading session at $18.29, gaining 9.1% over the past four weeks, but there could be plenty of upside left in the stock
Trading CEZ AS
Trading CEZ AS







